1	the participant be use valproate for control his/her seizure they be eligible for the study if they have not take valproate within 3 week prior to baseline visit and willing to not take it for the entire study duration valproate be an aed that partially inhibit the tca cycle via alpha-ketoglutarate|valproate[23,32]|||||||3 week[131,137]||C0080356|40254|40254|valproate
1	the participant be use valproate for control his/her seizure they be eligible for the study if they have not take valproate within 3 week prior to baseline visit and willing to not take it for the entire study duration valproate be an aed that partially inhibit the tca cycle via alpha-ketoglutarate|valproate[114,123]|||||||||C0080356|40254|40254|valproate
1	the participant be use valproate for control his/her seizure they be eligible for the study if they have not take valproate within 3 week prior to baseline visit and willing to not take it for the entire study duration valproate be an aed that partially inhibit the tca cycle via alpha-ketoglutarate|alpha - ketoglutarate[280,299]||||||||||17510|17510|alpha-ketoglutarate
2	dehydrogenase and should not be administer to subject take triheptanoin|triheptanoin[359,371]||||||||||1313234|1313234|triheptanoin
